This is an innovative test designed to offer insight into the critical biochemical methylation pathway. Because of its all-encompassing role in basic human physiology, the range of symptoms associated with methylation defects is broad. The Methylation Panel can offer insight in patients with:

• Cancer risk
• Cardiovascular disease (non-coronary atherosclerosis, hypertension, coronary artery disease)
• Psychiatric and mood disorders (schizophrenia, bipolar disorder, anxiety, depression)
• Neurologic disorders (Parkinson’s disease, cognitive decline)
• Chronic fatigue
• Questionable detoxification (patients who take hormone therapy, drink alcohol, or have toxin exposure)

NutraNourish METHYLATION Report Provides:

• The level of impact of any genetic variants identified
• Appropriate nutritional, supplement and lifestyle recommendations to support healthy methylation
• Cardiovascular disease (non-coronary atherosclerosis, hypertension, coronary artery disease)
• Psychiatric and mood disorders (schizophrenia, bipolar disorder, anxiety, depression)
• Neurologic disorders (Parkinson’s disease, cognitive decline)